These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15892830)

  • 1. Evergreening: there's life in the old drug yet.
    Wyllie MG
    BJU Int; 2005 Jun; 95(9):1359-60. PubMed ID: 15892830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tamsulosin in the sustained-release capsule -- continuously effective and economical].
    MMW Fortschr Med; 2006 Apr; 148(17):56-7. PubMed ID: 16711490
    [No Abstract]   [Full Text] [Related]  

  • 3. Tamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses.
    Nargund VH; Grey AD
    Expert Opin Pharmacother; 2008 Apr; 9(5):813-24. PubMed ID: 18345957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of regional mechanisms responsible for poor oral absorption in humans of a modified release preparation of the alpha-adrenoreceptor antagonist, 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): the rational use of ex vivo intestine to predict in vivo absorption.
    Collett A; Stephens RH; Harwood MD; Humphrey M; Dallman L; Bennett J; Davis J; Carlson GL; Warhurst G
    Drug Metab Dispos; 2008 Jan; 36(1):87-94. PubMed ID: 17932223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.
    Rovner ES; Kreder K; Sussman DO; Kaplan SA; Carlsson M; Bavendam T; Guan Z
    J Urol; 2008 Sep; 180(3):1034-41. PubMed ID: 18639297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release tamsulosin hydrochloride from alginate beads with waxy materials.
    Kim MS; Park GD; Jun SW; Lee S; Park JS; Hwang SJ
    J Pharm Pharmacol; 2005 Dec; 57(12):1521-8. PubMed ID: 16354396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL).
    Michel MC; Chapple CR
    Eur Urol; 2006 Mar; 49(3):501-8; discussion 508-9. PubMed ID: 16442211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
    Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
    Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supreme Court rules against drug patent "evergreening".
    Kondro W
    CMAJ; 2006 Dec; 175(12):1508-9. PubMed ID: 17146081
    [No Abstract]   [Full Text] [Related]  

  • 10. [A trial in treatment of gonorrhea with a sulphonamide with prolonged effect(sulfapherin)].
    Jorgensen BL
    Ugeskr Laeger; 1971 Jul; 133(26):1257-8. PubMed ID: 5561965
    [No Abstract]   [Full Text] [Related]  

  • 11. [Using of alpha1-adrenoreceptor blockers in urologic practice].
    Shaplygin LV
    Voen Med Zh; 2007 Jul; 328(7):40-7. PubMed ID: 17902344
    [No Abstract]   [Full Text] [Related]  

  • 12. One drug fits all.
    Wyllie MG
    BJU Int; 2005 Sep; 96(4):677-8. PubMed ID: 16104930
    [No Abstract]   [Full Text] [Related]  

  • 13. Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
    Chiu G; Li S; Cai H; Connolly PJ; Peng S; Stauber K; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6123-8. PubMed ID: 17904840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New practical synthesis of Tamsulosin.
    Gizur T; Fogassy E; Bálint J; Egri G; Törley J; Demeter A; Greiner I
    Chirality; 2008 Jun; 20(6):790-5. PubMed ID: 18306291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classical vs reverse pharmacology in drug discovery.
    Takenaka T
    BJU Int; 2001 Sep; 88 Suppl 2():7-10; discussion 49-50. PubMed ID: 11589663
    [No Abstract]   [Full Text] [Related]  

  • 16. Tablet induced dysphagia in oesophageal cancer.
    Selinger CP; Clements DG
    Gut; 2006 Apr; 55(4):587-8. PubMed ID: 16531546
    [No Abstract]   [Full Text] [Related]  

  • 17. [Delayed-action sulfonamides: Fanasil. Comprehensive study].
    Leng-Lévy J; David-Chaussé J
    J Med Bord; 1966 May; 143(5):739-44. PubMed ID: 5943724
    [No Abstract]   [Full Text] [Related]  

  • 18. [Considerations on plans for dosage of delayed-action sulfamides].
    Plancher AC; Salvi G; Strata A; Valdrè MV
    Clin Ter; 1967 Feb; 40(4):334-9. PubMed ID: 6077853
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery and optimisation of a potent and selective tertiary sulfonamide oxytocin antagonist.
    Barton NP; Bellenie BR; Doran AT; Emmons AJ; Heer JP; Salvagno CM
    Bioorg Med Chem Lett; 2009 Jan; 19(2):528-32. PubMed ID: 19081251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral separation of tamsulosin by capillary electrophoresis.
    Maier V; Horáková J; Petr J; Tesarová E; Coufal P; Sevcík J
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):691-6. PubMed ID: 15935602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.